Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture

5 (1 vote)

Recorded On: 11/11/2018

This lecture will examine the intersection of hepatobiliary neoplasia and liver transplantation to highlight what is currently working well, including liver transplantation for early stage hepatocellular carcinoma and hilar cholangiocarcinoma, as well as less common indications such as euroendocrine tumors. The speaker will highlight continued challenges, particularly related to overall disease burden, organ availability and allocation policy, and transplantation for more advanced tumors. A discussion of future challenges will explore opportunities for a multi-disciplinary approach using novel systemic therapies that are becoming available for advanced liver disease and advanced malignancy.

Julie Heimbach

Julie K. Heimbach, M.D., is a Professor of Surgery and Chair of the Division of Transplantation Surgery at Mayo Clinic in Rochester, Minnesota.  She is currently on the council of the American Society of Transplant Surgeons; and recently served a member of the Governing Board of the AASLD and as chair of the Liver and Intestinal Transplant Committee of UNOS.   She also serves as associate editor of AJT and Journal of Hepatology.  Her interests are in liver transplantation in the setting of malignancy, particularly hilar cholangiocarcinoma, as well as the management of obesity in liver transplantation and living donor transplantation. 


Liver Transplant for Hepatobiliary Neoplasia – Current Challenges and Opportunities
Open to view video.
Open to view video. Presenter: Julie Heimbach